Article metrics

0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

 

Online download statistics by month:

Online download statistics by month:

No statistics are available.